image
Healthcare - Biotechnology - NASDAQ - FR
$ 1.47
5 %
$ 163 M
Market Cap
-2.19
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
5.79%
EBIT Estimate
6.05%
Net Income Estimate
18.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Cellectis S.A.
image
CLLS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart CLLS

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CLLS

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CLLS

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029